<DOC>
	<DOCNO>NCT00003029</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug give drug different way may kill tumor cell . It yet know whether fluorouracil plus cisplatin effective fluorouracil alone treat patient metastatic cancer pancreas . PURPOSE : Randomized phase III trial compare effectiveness fluorouracil without cisplatin treat patient advanced metastatic cancer pancreas .</brief_summary>
	<brief_title>Fluorouracil With Without Cisplatin Treating Patients With Advanced Metastatic Cancer Pancreas</brief_title>
	<detailed_description>OBJECTIVES : - Confirm value chronomodulated infusion respect survival patient locally advance metastatic pancreatic cancer . - Test value add cisplatin fluorouracil extend survival patient . OUTLINE : This multicenter , randomize study . The study design 2 X 2 factorial patient allocate one 4 treatment group involve use absence chronomodulation cisplatin ( CDDP ) . Treatment 4 group repeat 3 course course 5-day course treatment . Patients first group receive chronomodulated schedule base delivery fluorouracil ( FU ) . Patients second group receive chronomodulated schedule FU CDDP . Patients third fourth experimental group receive flat schedule FU alone FU CDDP , respectively . Dosages FU increase across three course whereas dosage CDDP remain constant . Treatment continue disease progression , severe toxicity , complete remission 4 month occurs . PROJECTED ACCRUAL : 200 patient accrue .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologic cytologic proof adenocarcinoma exocrine pancreas metastasis associate radiologically identify pancreatic tumor Locally advance and/or metastatic pancreatic cancer No measurable evaluable target lesion require No brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 40 % 100 % Hematopoietic : WBC least 3,000/mm^3 Neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 3 time normal Renal : Creatinine great 1.24 mg/dL OR Creatinine clearance least 80 mL/min Cardiovascular : No overt cardiac disease Other : No peripheral neuropathy No uncontrolled infectious chronic disease No second primary except situ carcinoma cervix , basal squamous cell carcinoma skin PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent immunologic therapy Chemotherapy : No prior chemotherapy allow Endocrine therapy : No concurrent hormonal therapy At least 2 week since corticoid treatment Radiotherapy : No prior radiotherapy allow except analgesic treatment metastasis Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>adenocarcinoma pancreas</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>